You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Merck: FDA reviewing its ragweed allergy therapy

WHITEHOUSE STATION, N.J. — Drug maker Merck & Co. said the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic­ reactions over time, rather than just relieving sneezing, itching, and other symptoms temporarily.

Merck’s latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves under the tongue.

Continue reading below

Patients in studies of the tablet took it daily for a year. It could become an alternative to months of uncomfortable allergy­ shots.

Both methods gradually desensitize the immune system to the substance triggering the allergic reaction.

In March, the Whitehouse Station, N.J., company said the FDA was reviewing its application for an immunotherapy pill for grass pollen allergies.

Merck expects FDA rulings on both still-unnamed treatments in 2014’s first half.

Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.